MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/07/2022 30/06/2027 Topic: Biomarkers identification Project type: Preclinic Project target: Liver cancer Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE THE UNIVERSITY OF TEXAS SYSTEM Keywords: liver cancer; oncology; tumour; cihrosis; biomarker; hepatology; HCC; claudin-1; Countries: France; USA Project...

Dates: 01/01/2021 31/12/2025 Topic: Tool Project type: Preclinic Immunotherapy Theranostic Project target: Skin Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: WEIZMANN INSTITUTE OF SCIENCE Keywords: oncology; melanoma; tumour; protein; immunotherapy; Itme; microenviroment; machine learning; platform Countries: Israel Project page: Access page  

Dates: 01/04/2020 31/03/2025 Topic: Biomarkers identification Project type: Immunotherapy Preclinic Clinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITY OF CYPRUS Keywords: biomarker; oncology; tumour; immunotherapy; model; biomechanic Countries: Cyprus Project page: Access page  

Dates: 01/10/2020 30/09/2025 Topic: Tool Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN Keywords: oncology; ion beam; CPT; charged-particule therapy; radioactivity; nuclear physics; imaging; chemotherapy Countries: Germany Project page: Access page  

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Prostate Cancer Colorectal Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: reinforcement; drug resistance; colorectal cancer; prostate cancer; oncology; monotherapy; HTS Countries: Germany Project page: Access page...

Dates: 01/01/2021 30/06/2026 Topic: Tool Project type: Theranostic Preclinic Project target: Cancer Neurology Financing: H2020-EU.4.c. – Establishing ‚ERA Chairs’ Participating agents: INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA Keywords: medical technology; nanotechnology; oncology; infection; neurodegenerative; tissue; molecular bioengineering; therapy Countries: Portugal Project page: Access page  

Dates: 01/06/2020 31/05/2025 Topic: Tool Project type: Preclinic Theranostic Project target: Breast Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: 4D; imaging; tissue; X-ray; CT; tomography; tumour; surgery; oncology; breast cancer Countries: Netherlands Project page: Access page  

Dates: 22/03/2021 21/03/2024 Topic: Tool Project type: Preclinic Theranostic Project target: Ovarian Cancer Financing: H2020-EU.1.3.2. – Nurturing excellence by means of cross-border and cross-sector mobility Participating agents: DUBLIN CITY UNIVERSITY -COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH Keywords: synthetic biology; tissue engineering; transition metals; oncology; screening; drug resistance; theranostic Countries: Ireland; South Africa Project page: Access...

Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...